Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of mefloquine for preventing malaria in pregnant women. Specifically, to evaluate the:
•efficacy, safety and tolerability of mefloquine for preventing malaria in pregnant women.
•effect of HIV status, gravidity and ITN use on mefloquine efficacy.
| Original language | English |
|---|---|
| Article number | CD011444 |
| Pages (from-to) | CD011444 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2015 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 14 Jan 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Mefloquine for preventing malaria in pregnant women'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver